about
Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia.Estimation of patient accrual rates in clinical trials based on routine data from hospital information systems.[Long-term results following tonsillotomy in children].Evaluation of different biomarkers to predict individual radiosensitivity in an inter-laboratory comparison--lessons for future studies.Factors influencing life satisfaction in acute myeloid leukemia survivors following allogeneic stem cell transplantation: a cross-sectional studyThe soluble VEGF receptor sFlt1 contributes to endothelial dysfunction in CKD.Therapeutic strategies evaluated by the European Society of Cutaneous Lupus Erythematosus (EUSCLE) Core Set Questionnaire in more than 1000 patients with cutaneous lupus erythematosus.Strain Elastography as a New Method for Assessing Pelvic Floor Biomechanics.Multicentric investigation of ionising radiation-induced cell death as a predictive parameter of individual radiosensitivity.Calcineurin inhibitor-free immunosuppression using everolimus (Certican) after heart transplantation: 2 years' follow-up from the University Hospital Münster.Disinfection of transvaginal ultrasound probes in a clinical setting: comparative performance of automated and manual reprocessing methods.Renal oligo- and anhydramnios: cause, course and outcome--a single-center study.Success rates of retinal buckling surgery: relationship to refractive error and lens status: results from a large German case series.The value of high-dose chemotherapy in patients with first relapsed Ewing sarcoma.Cross-reactive carbohydrate determinants strongly affect the results of the basophil activation test in hymenoptera-venom allergy.Prospective study of everolimus with calcineurin inhibitor-free immunosuppression after heart transplantation: results at four years.High phosphate directly affects endothelial function by downregulating annexin II.Updated analysis of standardized photoprovocation in patients with cutaneous lupus erythematosus.Assessment of first-trimester thymus size and correlation with maternal diseases and fetal outcome.Influence of smoking on disease severity and antimalarial therapy in cutaneous lupus erythematosus: analysis of 1002 patients from the EUSCLE database.Implantation and follow-up of totally subcutaneous versus conventional implantable cardioverter-defibrillators: a multicenter case-control study.Evaluation of disease activity and damage in different subtypes of cutaneous lupus erythematosus using the CLASI.Lupus erythematosus tumidus is a separate subtype of cutaneous lupus erythematosus.Importance of Transvaginal Elastography in the Diagnosis of Uterine Fibroids and AdenomyosisImaging of fetal thymus in pregnant women with rheumatic diseasesCutaneous lupus erythematosus: First multicenter database analysis of 1002 patients from the European Society of Cutaneous Lupus Erythematosus (EUSCLE)Outcome of surgery after macula-off retinal detachment - results from MUSTARD, one of the largest databases on buckling surgery in EuropeProspective Study of Everolimus With Calcineurin Inhibitor-Free Immunosuppression in Maintenance Heart Transplant Patients: Results at 2 YearsA Database Analysis of Cutaneous Lupus Erythematosus with the EUSCLE Core Set QuestionnaireRevised Cutaneous Lupus erythematosus Disease Area and Severity Index (RCLASI): a modified outcome instrument for cutaneous lupus erythematosusBlood pressure, antihypertensive treatment, and graft survival in kidney transplant patients
P50
Q27853390-E5D57DC0-B5E7-4A23-9075-527E226F0DC6Q33433922-A9625724-1AE8-4CF7-B55D-E15435D8A1CCQ33553639-A5E4FD48-5A2F-4DFC-8DAD-8CE289581700Q34460363-57D64847-9F15-45E8-BE3D-C6B851A274A3Q35146910-86AF0F23-A4AE-4EFB-86F2-91E2AA6E6DADQ37367745-421EC60E-6AF3-4552-84F6-97446BFE5A27Q38065665-04425CE6-AE4D-42E1-858E-B7DF2C2D497DQ39009318-7F8CC1B0-5275-4FF9-A2C6-A7E4A0480D05Q39895651-753A06A5-884A-47A6-83EE-D07CBC4D8E03Q40321027-D777EB14-88BD-4C01-A6F4-BAB36E0DC193Q40478073-85C60B6D-B457-402C-AFAD-4B9D33308286Q41443556-3064E95B-1FA8-4282-A860-A16106E9CAD1Q43140974-79FD0C28-ACC4-4331-B198-7EC920F9A91CQ43833260-E4D2211E-88DB-4BB1-9FB9-1CA955540112Q44080547-2BD92FB4-2BC5-4AB0-BD5A-00BA67B21997Q44241749-9E7FC85C-166C-401B-A895-6F0E96166F0CQ44470575-47EC8FE4-EE54-468E-AB0B-FBC891192715Q44496885-10D9A4C7-E88C-48AC-864B-A2BB1F5C36D8Q47355935-A2117C03-BC89-4318-805D-04B5DFA50BA9Q51150943-C8A3BE3E-038B-4547-847C-D0EF8C0177CDQ51306298-AA2D6431-1199-43E4-A6FA-AF01A1E37D3BQ51541832-6E854A1A-D6E3-4AC7-A187-ABF2577FF952Q53188386-E47E6E95-030C-4C4C-83BE-19C2BF3954EEQ60048109-FB570CB2-814C-4580-8C49-F44A1EAC0E58Q60048135-37AE9461-6608-4187-8FCA-5A7623CD4A87Q60048153-B391A49A-5958-419A-9221-BCABB45E9070Q60048232-1172147A-F965-46AE-BC19-433C1064650FQ60048280-FBB80108-6DFB-4FAE-871E-37B9F703D43CQ60048297-F886FD28-BF58-416F-8CA8-9110CB7F8E3CQ60048342-55A96E57-9A94-4288-A380-6C3C0619C85BQ60048359-6324614E-D1CF-4569-AAA6-803BA2AC05D4
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
ricercatrice
@it
հետազոտող
@hy
name
Susanne Amler
@ast
Susanne Amler
@en
Susanne Amler
@es
Susanne Amler
@nl
Susanne Amler
@sl
type
label
Susanne Amler
@ast
Susanne Amler
@en
Susanne Amler
@es
Susanne Amler
@nl
Susanne Amler
@sl
prefLabel
Susanne Amler
@ast
Susanne Amler
@en
Susanne Amler
@es
Susanne Amler
@nl
Susanne Amler
@sl
P106
P21
P214
27147121635926391069
P31
P496
0000-0001-6903-2906
P735
P7859
viaf-27147121635926391069